Articles From: B/E Aerospace Announces Closing of Offering of Senior Notes by KLX to Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma


B/E Aerospace, Inc. (“B/E Aerospace” or the “Company”) (NASDAQ:BEAV) announced today that its wholly-owned subsidiary KLX Inc. (“KLX”) has successfully closed its previously announced offering of $1.2 billion aggregate principal amount of 5.875% senior notes due 2022 (the “Notes”). The Notes were issued at 100% of the aggregate principal amount.
Sign-up for B/E Aerospace Announces Closing of Offering of Senior Notes by KLX investment picks
Keysight Technologies, Inc. (NYSE:KEYS) today announced that they have joined the NYU WIRELESS university research center as a key sponsor of the fundamental groundwork that the research center is laying for a new generation of wireless technologies, also known as 5G.
Sign-up for TRADE NEWS: Keysight Technologies Joins NYU WIRELESS to Advance 5G Mobile Technology investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983024001&sourceType=1 http://media3.marketwire.com/logos/20130113-cgi_logo_b.jpg MONTREAL, QUEBEC --
Sign-up for CGI to present at the BMO Technology and Digital Media Conference on December 10 in New York City investment picks
LAKEVILLE, Conn., Dec.
Sign-up for Salisbury Bancorp, Inc. Announces Completion of Merger investment picks
Orbit Garant Drilling announces changes to Board of Directors Canada NewsWire VAL-D'OR, QC , Dec.
Sign-up for Orbit Garant Drilling announces changes to Board of Directors investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical translational data showing the complementary effects of inhibiting both PI3K-delta and PI3K-gamma , two enzymes known to play a role in regulating the growth and survival of certain types of potentially fatal blood cancers, including indolent non-Hodgkin lymphoma (iNHL) and chronic lymphocytic leukemia (CLL). This translational research also highlights the important role that PI3K-gamma plays in forming and maintaining the protective tumor microenvironment.
Sign-up for Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology Compound Duvelisib at American Society of Hematology Annual Meeting investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983036001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20100514-bmocapi.jpg NEW YORK, NEW YORK --
Sign-up for REPEAT/Media Advisory: BMO Capital Markets to Host Technology & Digital Media Conference investment picks
http://media.marketwire.com/attachments/201403/235782_White-Logo-Medium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163597&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Easton Pharmaceuticals Announces Positive Updates, Changes to Its OTC Therapeutic Products, Manufacturing and North American Distributorship investment picks
Airline continues legacy as the hometown carrier that cares DALLAS , Dec.
Sign-up for Southwest Airlines Recognized For Commitment To Community By Bloomberg LP And Points Of Light investment picks
EBay Inc. (EBAY) shares rose Monday by 1.2% to $55.49 after Stifel Nicolaus analyst Scott Devitt raised his rating on the e-commerce company to buy from hold.
Sign-up for EBay gets a lift after Stifel raises rating to buy investment picks
Forestar Group Inc. ("Forestar") (NYSE: FOR) today announced that its Board of Directors, working together with its management team and financial advisor, Goldman, Sachs & Co., is exploring strategic alternatives to enhance shareholder value.
Sign-up for Forestar Announces Plan to Explore Strategic Alternatives to Enhance Shareholder Value investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G028018-001&sourceType=1 NEW YORK, NY--(Marketwired - December 08, 2014) - JetBlue Airways (NASDAQ: JBLU), New York's Hometown Airline™, today announces the appointment of Alexander Chatkewitz as the carrier's new Vice President, Controller.
Sign-up for JetBlue Appoints Alexander Chatkewitz Vice President, Controller investment picks
Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced oral and poster presentations at the 2014 American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 6 - 9, 2014, in San Francisco.
Sign-up for Verastem Presents Data at the 2014 American Society of Hematology Annual Meeting investment picks
CANONSBURG, Pa.
Sign-up for CONE Midstream To Participate In Wells Fargo Energy Symposium investment picks
The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference in New York, NY on Wednesday, December 10 th at 9:10 AM EST.
Sign-up for The Medicines Company to Participate in Oppenheimer 25th Annual Healthcare Conference investment picks
December 8, 2014-- Comtech Telecommunications Corp.
Sign-up for Comtech Telecommunications Corp. Receives $7.4 Million in Additional Orders Relating to a Satellite System Project for End-Use by the Brazilian Military investment picks
BILLERICA, Mass., Dec.
Sign-up for CSP Inc. Announces Key Executive Management Team Appointment investment picks
Accenture (NYSE:ACN) and Microsoft Corp.
Sign-up for Accenture and Microsoft Launch New Hybrid Cloud Platform to Accelerate Enterprise-Wide Adoption investment picks
ATLANTA , Dec.
Sign-up for Equifax to Present at Barclays Global Technology Conference investment picks
ADVISORY, Dec.
Sign-up for Windstream (Nasdaq: WIN) to Ring The Nasdaq Stock Market Opening Bell investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted multiple ADCETRIS (brentuximab vedotin) data presentations in frontline and salvage Hodgkin lymphoma (HL) at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition taking place in San Francisco, CA, December 6-9, 2014.
Sign-up for Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting investment picks
Ellie Mae ® (NYSE: ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, today announced that author, professor and business management expert Don Tapscott will be among the keynote speakers at the 2015 Ellie Mae Encompass Experience conference on February 22-25 in Orlando, Florida.
Sign-up for Author Don Tapscott to Keynote 2015 Ellie Mae Encompass Experience Conference investment picks
Sundance Strategies, Inc. (OTCBB: SUND), an innovative company engaged in acquiring life insurance settlements and related insurance contracts, policies and obligations, today announced that it has signed a binding Letter of Intent (“LOI”) to acquire a portfolio of life insurance policies from a life settlement fund.
Sign-up for Sundance Strategies Signs Binding Letter of Intent to Acquire Portfolio of Life Insurance Policies with Face Value of Approximately $124 Million investment picks
Avnet, Inc. (NYSE: AVT ), a leading global technology distributor, today announced that Marianne McDonald, vice president of global transportation, Avnet, Inc., will present a session titled “What’s the Big Deal with Big Data?” at the 12 th Annual American Supply Chain and Logistics Summit.
Sign-up for Avnet, Inc.’s Marianne McDonald to Present at American Supply Chain and Logistics Summit investment picks
Gilead Sciences, Inc. (NASDAQ: GILD) today announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and safety profile for Zydelig ® (idelalisib) in relapsed patients with chronic lymphocytic leukemia (CLL) and two types of indolent non-Hodgkin lymphoma (iNHL). The findings are being presented this week at the Annual Meeting of the American Society of Hematology (ASH). Zydelig is indicated in the United States as monotherapy for patients with relapsed follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL) who have received at least two prior systemic therapies, and in combination with rituximab for patients with relapsed CLL for whom rituximab alone would be considered appropriate therapy due to comorbidities.
Sign-up for Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: B/E Aerospace Announces Closing of Offering of Senior Notes by KLX to Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent